ER staining levels affect HER2 staining and heterogeneity.

导出原文传递

翻译打印收藏纠错

作者： Momoko,Akashi ^[1] ; Rin,Yamaguchi ^[2] ; Hironori,Kusano ^[3] ; Miki,Yamaguchi ^[4] ; Jun,Akiba ^[1] ; Tatsuyuki,Kakuma ^[5] ; Maki,Tanaka ^[6] ; Yoshito,Akagi ^[7] ; Hirohisa,Yano ^[5]

作者单位： Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka, Japan. ^[1] Department of Breast Surgery, National Hospital Organization Kyushu Medical Center, Fukuoka, Fukuoka, Japan. ^[2] Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka, Japan. rin@med.kurume-u.ac.jp. ^[3] Department of Pathology and Laboratory Medicine, Kurume University Medical Center, 155-1 Kokubu, Kurume, Fukuoka, 859-0863, Japan. rin@med.kurume-u.ac.jp. ^[4] Departmen of Surgery, Japan Community Healthcare Organization Kurume General Hospital, Kurume, Fukuoka, Japan. ^[5] Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Fukuoka, Japan. ^[6] Biostatistics Center, Kurume University School of Medicine, Kurume, Fukuoka, Japan. ^[7] Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka, Japan. ^[8]

关键词 HER2 ASCO/CAP guideline HER2 positive breast carcinoma HER2 staining; heterogeneity Hormone receptor